Seattle Genetics (SGEN) to Receive Multi-Million Milestone Under ADCETRISTM Collaboration
Tweet Send to a Friend
Seattle Genetics, Inc., (Nasdaq: SGEN), will receive a $5 million milestone payment under its brentuximab ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
